MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$17,971K
EPS
-$0.13
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
13,138
13,606
28,563*
17,441
General and administrative
5,133
5,360
8,037*
5,091
Impairment charge
-
-
-6,350*
-
Lease termination (gain) and impairment charge
238
-
-
-
Total operating expenses
18,033
18,966
30,250
22,532
Loss from operations
-18,033
-18,966
-30,250*
-22,532
Interest income
1,508
1,182
1,102*
802
Interest expense
285
331
383*
408
Other expense, net
-257
188
-24*
-6
Loss before income taxes
-
-
-29,555*
-
Income tax provision
-
-
0*
-
Loss on debt extinguishment
-904
-
-
-
Net loss
-17,971
-17,927
-29,555
-22,144
Basic EPS
-0.13
-0.17
-0.548
-0.41
Diluted EPS
-0.13
-0.17
-0.548
-0.41
Basic Average Shares
135,639,684
104,573,657
53,952,500
53,577,066
Diluted Average Shares
135,639,684
104,573,657
53,952,500
53,577,066
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$17,971K
(30.74%↑ Y/Y)
Interest income
$1,508K
(36.35%↑ Y/Y)
Loss from operations
-$18,033K
(32.33%↑ Y/Y)
Loss on debt
extinguishment
-$904K
Interest expense
$285K
(-29.63%↓ Y/Y)
Other expense, net
-$257K
(-12750.00%↓ Y/Y)
Total operating
expenses
$18,033K
(-32.33%↓ Y/Y)
Lease termination
(gain) and impairment...
$238K
Research and development
$13,138K
(-27.10%↓ Y/Y)
General and
administrative
$5,133K
(-5.83%↓ Y/Y)
Buy us a coffee
ALX ONCOLOGY HOLDINGS INC (ALXO)
ALX ONCOLOGY HOLDINGS INC (ALXO)